MAPK3 and type 2 diabetes mellitus: Also, stimulation of the MAPK/ERK1,2 pathway with thrombin in HSVSMCs from either non-diabetic (Figure 6A) or T2DM patients (Figure 6C) did not alter the generation of mROS.